Minimizing tolerance and withdrawal to prolonged pediatric sedation: Case report and review of the literature

Journal of Intensive Care Medicine

Volumn 22, Issue 3, 2007, Pages 173-179

  Cho, Hannah H ^a,c   O'Connell, James P ^b   Cooney, Maureen F ^b   Inchiosa Jr , Mario A ^b  

^a Sound Shore Medical Center of Westchester   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NONE   (United States)

Author keywords

Analgesics; Critical illness; Drug tolerance; Drug withdrawal; Hypnotics and sedatives; Pediatrics; Prolonged sedation

Indexed keywords

CLONAZEPAM; CLONIDINE; FENTANYL; METHADONE; METHYLPHENIDATE; MIDAZOLAM; MORPHINE SULFATE; PROPOFOL;

ATTENTION DEFICIT DISORDER; BURN; CHOREOATHETOSIS; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CRITICAL ILLNESS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DRUG DOSE REDUCTION; DRUG TOLERANCE; ELECTRIC BURN; HUMAN; INTENSIVE CARE UNIT; MEDICAL EXAMINATION; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SEDATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

BURN UNITS; CHILD; CONSCIOUS SEDATION; DRUG TOLERANCE; FENTANYL; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34250173109     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066607299556     Document Type: Review

References (35)

1. Robert R., Brack A., Blakeney P., et al. A double-blind study of the analgesic efficacy of oral transmucosal fentanyl citrate and oral morphine in pediatric patients undergoing burn dressing change and tubbing. J Burn Care Rehabil. 2003 ; 24: 351-355.
2. Tobias JD Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000 ; 28: 2122-2132.
3. Twite MD, Rashid A., Zuk J., Friesen RH Sedation, analgesia and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med. 2004 ; 5: 521-532.
4. de Wildt SN, Kearns GL, Hop Wcj, Murry DJ, Abdel-Rahman SM, van den Anker JN. Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clin Pharmacol Ther. 2001 ; 70: 525-531.
5. Bauer TM, Ritz R., Haberthur C., et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. The Lancet. 1995 ; 346: 145-147.
6. Blumer JL Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet. 1998 ; 35: 37-47.
7. Cravero JP, Blike GT Review of pediatric sedation. Anesth Analg. 2004 ; 99: 1355-1364.
8. Mosby's Drug Consult. 15 th ed. St Louis: Mosby Inc ; 2005: II - 1926.
9. Sury Mrj, Billingham I., Russell GN, Hopkins CS Acute benzodiazepine withdrawal syndrome after midazolam infusions in children. Crit Care Med. 1989 ; 17: 301-302.
10. Tobias JD Fentanyl for sedation in the pediatric intensive care unit: dealing with the problems. J Pharm Care Pain Symptom Control. 1996 ; 4: 21-32.
11. Tobias JD, Berkenbosch JW Tolerance during sedation in a pediatric ICU patient: effects on the BIS monitor. J Clin Anesth. 2001 ; 13: 122-124.
12. Arnold JH, Truog RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr. 1991 ; 119: 639-643.
13. Katz R., Kelly HW Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med. 1993 ; 21: 995-1000.
14. Charney DS, Mihic SJ, Harris RA Hypnotics and sedatives. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10 th ed. New York, NY: McGraw-Hill ; 2001: 399-427.
15. Martyn J. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology. 1986 ; 65: 67-75.
16. Hollister LE, Motzenbecker FP, Degan RO Withdrawal reactions from chlordiazepoxide. Psychopharmacologia. 1961 ; 2: 63-68.
17. Lane JC, Tennison MB, Lawless ST, Greenwood RS, Zaritsky AL Movement disorder after withdrawal of fentanyl infusion. J Pediatr. 1991 ; 119: 649-651.
18. Bergman I., Steeves M., Burkart G., Thompson A. Reversible neurologic abnormalities associated with prolonged IV midazolam and fentanyl administration. J Pediatr. 1991 ; 119: 644-649.
19. Fonsmark L., Rasmussen H., Carl P. Occurrence of withdrawal in critically ill sedated children. Crit Care Med. 1999 ; 27: 196-199.
20. Katz R., Kelly HW, Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med. 1994 ; 22: 763-767.
21. De Jonghe B, Cook D., Appere-De-Vecchi C, Guyatt G, Meade M, Outin H. Using and understanding sedation scoring systems: a systematic review. Intensive Care Med. 2000 ; 26: 275-285.
22. Ely EW, Truman B., Shintani A., et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003 ; 289: 2983-2991.
23. Society of Critical Care Medicine, American Society of Health-System Pharmacists. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Am J Health Syst Pharm. 2002 ; 59: 150-178.
24. LeBlanc JM, Dasta JF, Kane-Gill SL. Role of the bispectral index in sedation monitoring in the ICU. Ann Pharmacother. 2006 ; 40: 490-500.
25. Cunliffe M., McArthur L., Dooley F. Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward. Paediatr Anaesth. 2004 ; 14: 293-298.
26. Playfor SD, Thomas DA, Choonara I. Sedation and neuromuscular blockade in paediatric intensive care: a review of current practice in the UK. Paediatr Anaesth. 2003 ; 13: 147-151.
27. Kress JP, Pohlman AS, O'Conner MF. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000 ; 342: 1471-1477.
28. Schweickert WD, Gehlbach BK, Pohlman As, et al. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med. 2004 ; 32: 1272-1276.
29. Kissin I., Bright C., Bradley E. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg. 2000 ; 91: 1483-1488.
30. Suresh S., Anand Kjs. Opioid tolerance in neonates: a state-of-the-art review. Paediatr Anaesth. 2001 ; 11: 511-521.
31. Tobias J., Schleien C., Haun S. Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care unit patients. Crit Care Med. 1990 ; 18: 1292-1293.
32. Robertson RC, Darsey E., Fortenberry JD, Pettignano R., Hartley G. Evaluation of an opiate-weaning protocol using methadone in pediatric intensive care unit patients. Pediatr Crit Care Med. 2000 ; 1: 119-123.
33. Jacobi J., Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002 ; 30: 119-141.
34. Deutsch ES, Nadkarni VM Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg. 1996 ; 122: 1234-1238.
35. Brown C., Albrecht R., McFadden T., Schermer C., Pettit H. Opioid and benzodiazepine withdrawal syndrome in adult burn patients. Am Surg. 2000 ; 66: 367-371.